Expression of purinergic P2Y receptor subtypes by INS-1 insulinoma beta-cells: a molecular and binding characterization - PubMed (original) (raw)

. 2007 Jul 30;568(1-3):54-60.

doi: 10.1016/j.ejphar.2007.04.012. Epub 2007 Apr 20.

Affiliations

• PMID: 17509560
• DOI: 10.1016/j.ejphar.2007.04.012

Expression of purinergic P2Y receptor subtypes by INS-1 insulinoma beta-cells: a molecular and binding characterization

Laura Lugo-Garcia et al. Eur J Pharmacol. 2007.

Abstract

Purinergic P2Y-receptor agonists amplify glucose-induced insulin secretion from pancreatic beta-cells, thus offering new opportunities for the treatment of type 2 diabetes. However, little is known about which subtypes of purinergic P2Y receptors are expressed in these cells. The INS-1 beta-cell line is used as a model of pancreatic beta-cells, expressing most of their properties. Therefore, we investigated the expression of different molecular subtypes in this cell line by means of real time Polymerase Chain Reaction and Western blot. We also performed a characterization of the binding of a prototypic purinergic P2Y agonist, Adenosine-5'-O-(1-[(35)S]thiotriphosphate) (ATP-alpha-[(35)S]), to cell membrane homogenates. The molecular analysis evidenced the presence of five different purinergic P2Y receptor subtypes (P2Y(1), P2Y(2), P2Y(4), P2Y(6) and P2Y(12)), which were expressed at similar levels. The Western blot analysis allowed detecting corresponding proteins. The binding assay demonstrated a specific ATP-alpha-[(35)S] interaction on high (40%) and low (60%) affinity components. The analysis of ATP-alpha-[(35)S] pharmacological profile on both sites permitted to classify the high affinity binding site as representative of the purinergic P2Y(1) receptor subtype and the low affinity binding site of the P2Y(4) and/or P2Y(6) receptor subtypes. ATP-alpha-S and Adenosine-5'-O-(2-thiodiphosphate) (ADP-beta-S) exhibited opposite selectivity on high and low affinity binding sites. Although purinergic P2Y(1) receptor, or a P2Y(1)-like subtype, has been generally considered as that implicated in the modulation of glucose-induced insulin release, the present data show that the beta-cell expresses a complex profile of purinergic P2Y receptor subtypes, the functional implication of which remains to be fully elucidated.

PubMed Disclaimer

Similar articles

• P2Y receptor activation enhances insulin release from pancreatic beta-cells by triggering the cyclic AMP/protein kinase A pathway.
  Chevassus H, Roig A, Belloc C, Lajoix AD, Broca C, Manteghetti M, Petit P. Chevassus H, et al. Naunyn Schmiedebergs Arch Pharmacol. 2002 Nov;366(5):464-9. doi: 10.1007/s00210-002-0620-4. Epub 2002 Sep 6. Naunyn Schmiedebergs Arch Pharmacol. 2002. PMID: 12382076
• Solubilization of a guanine nucleotide-sensitive form of the P2Y-purinergic receptor.
  Jeffs RA, Cooper CL, Harden TK. Jeffs RA, et al. Mol Pharmacol. 1991 Jul;40(1):85-92. Mol Pharmacol. 1991. PMID: 1906978
• P2Y receptor expression on astrocytes in the nucleus accumbens of rats.
  Franke H, Krügel U, Grosche J, Heine C, Härtig W, Allgaier C, Illes P. Franke H, et al. Neuroscience. 2004;127(2):431-41. doi: 10.1016/j.neuroscience.2004.05.003. Neuroscience. 2004. PMID: 15262333
• The enteric purinergic P2Y1 receptor.
  Wood JD. Wood JD. Curr Opin Pharmacol. 2006 Dec;6(6):564-70. doi: 10.1016/j.coph.2006.06.006. Epub 2006 Aug 24. Curr Opin Pharmacol. 2006. PMID: 16934527 Review.
• A retrospective of recombinant P2Y receptor subtypes and their pharmacology.
  Sak K, Webb TE. Sak K, et al. Arch Biochem Biophys. 2002 Jan 1;397(1):131-6. doi: 10.1006/abbi.2001.2616. Arch Biochem Biophys. 2002. PMID: 11747319 Review.

Cited by

• TRPM2 functions as a lysosomal Ca2+-release channel in beta cells.
  Lange I, Yamamoto S, Partida-Sanchez S, Mori Y, Fleig A, Penner R. Lange I, et al. Sci Signal. 2009 May 19;2(71):ra23. doi: 10.1126/scisignal.2000278. Sci Signal. 2009. PMID: 19454650 Free PMC article.
• Uridine triphosphate (UTP) induces profibrotic responses in cardiac fibroblasts by activation of P2Y2 receptors.
  Braun OO, Lu D, Aroonsakool N, Insel PA. Braun OO, et al. J Mol Cell Cardiol. 2010 Sep;49(3):362-9. doi: 10.1016/j.yjmcc.2010.05.001. Epub 2010 May 13. J Mol Cell Cardiol. 2010. PMID: 20471392 Free PMC article.
• Purinergic receptors in the endocrine and exocrine pancreas.
  Novak I. Novak I. Purinergic Signal. 2008 Sep;4(3):237-53. doi: 10.1007/s11302-007-9087-6. Epub 2007 Dec 11. Purinergic Signal. 2008. PMID: 18368520 Free PMC article.
• ATP released from cardiac fibroblasts via connexin hemichannels activates profibrotic P2Y2 receptors.
  Lu D, Soleymani S, Madakshire R, Insel PA. Lu D, et al. FASEB J. 2012 Jun;26(6):2580-91. doi: 10.1096/fj.12-204677. Epub 2012 Mar 13. FASEB J. 2012. PMID: 22415310 Free PMC article.
• Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes.
  Ahrén B. Ahrén B. Nat Rev Drug Discov. 2009 May;8(5):369-85. doi: 10.1038/nrd2782. Epub 2009 Apr 14. Nat Rev Drug Discov. 2009. PMID: 19365392 Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Ovid Technologies, Inc.